Počet záznamů: 1  

Antiviral activities of 2,6-diaminopurine-based acyclic nucleoside phosphonates against herpesviruses: In vitro study results with pseudorabies virus (PrV, SuHV-1)

  1. 1.
    SYSNO ASEP0463274
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevAntiviral activities of 2,6-diaminopurine-based acyclic nucleoside phosphonates against herpesviruses: In vitro study results with pseudorabies virus (PrV, SuHV-1)
    Tvůrce(i) Zouharová, D. (CZ)
    Lipenská, I. (CZ)
    Fojtiková, M. (CZ)
    Kulich, P. (CZ)
    Neca, J. (CZ)
    Slaný, M. (CZ)
    Kovařčík, K. (CZ)
    Turanek-Knotigová, P. (CZ)
    Hubatka, F. (CZ)
    Celechovská, H. (CZ)
    Mašek, J. (CZ)
    Koudelka, Š. (CZ)
    Procházka, L. (CZ)
    Eyer, L. (CZ)
    Plocková, J. (CZ)
    Bartheldyová, E. (CZ)
    Miller, A. D. (GB)
    Růžek, Daniel (BC-A) RID, ORCID
    Raška, M. (US)
    Janeba, Zlatko (UOCHB-X) RID, ORCID
    Turánek, J. (CZ)
    Zdroj.dok.Veterinary Microbiology. - : Elsevier - ISSN 0378-1135
    Roč. 184, FEB 29 (2016), s. 84-93
    Poč.str.10 s.
    Forma vydáníTištěná - P
    Jazyk dok.eng - angličtina
    Země vyd.NL - Nizozemsko
    Klíč. slovaPseudorabies ; Acyclic nucleoside phosphonates ; DNA viruses ; Cidofovir ; Antiviral drugs ; DNA polymerase
    Vědní obor RIVEE - Mikrobiologie, virologie
    Vědní obor RIV – spolupráceÚstav organické chemie a biochemie - Organická chemie
    Institucionální podporaBC-A - RVO:60077344 ; UOCHB-X - RVO:61388963
    UT WOS000370905900013
    EID SCOPUS84957708402
    DOI10.1016/j.vetmic.2016.01.010
    AnotacePseudorabies virus (PrV), a causative agent of Aujeszky's disease, is deadly to most mammals with the exception of higher primates and men. This disease causes serious economic loses among farm animals, especially pigs, yet many European countries are today claimed to be Aujeszky's disease free because of the discovery of an efficient vaccination for pigs. In reality, the virus is still present in wild boar. Current vaccines are neither suitable for dogs nor are there anti-PrV drugs approved for veterinary use. Therefore, the disease still represents a high threat, particularly for expensive hunting dogs that can come into close contact with infected boars. Here we report on the anti-PrV activities of a series of synthetic diaminopurine-based acyclic nucleoside phosphonate (DAP-ANP) analogues. Initially, all synthetic DAP-ANPs under investigation are shown to exhibit minimal cytotoxicity by MTT and XTT tests (1-100 mu M range). Thereafter in vitro infection models are established using PrV virus SuHV-1, optimized on PK-15 and RK-13 cell lines. Out of the six DAP-ANP analogues tested, analogue VI functionalized with a cyclopropyl group on the 6-amino position of the purine ring proves the most effective antiviral DAP-ANP analogue against PrV infection, aided by sufficient hydrophobic character to enhance bioavailability to its cellular target viral DNA-polymerase. Four other DAP-ANP analogues with functional groups introduced to the C2'position are shown ineffective against PrV infection, even with favourable hydrophobic properties. Cidofovir (R), a drug approved against various herpesvirus infections, is found to exert only low activity against PrV in these same in vitro models.
    PracovištěBiologické centrum (od r. 2006)
    KontaktDana Hypšová, eje@eje.cz, Tel.: 387 775 214
    Rok sběru2017
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.